<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Urea cycle and associated pathways" Version="20190411" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">The urea cycle converts toxic nitrogenous compounds to excretable urea in five biochemical reactions. It is also the source for endogenous arginine, ornithine and citrulline production. The process mainly takes place in the liver, partly in the mitochondria and partly in the cytoplasm of the hepatocytes. There are several pathways associated with  the urea cycle and with the associated disorders, parts of these pathways are also pictured here.  
Because there is no alternative way to convert toxic nitrogenous compounds, defects in the enzymes or transporters can lead to several diseases (diseases highlighted in pink). The diseases are characterised by hyperammonemia, respiratory alkalosis and encephalopathy and the severity of the disease depends on the severity of the defect and the place of the defect in the cycle. Severe forms usually have an onset in infancy, while mild forms can also present in adulthood. 
This pathway was inspired by Chapter 4 of the book of Blau (ISBN 3642403360 (978-3642403361)). 
For the Urea cycle without additional pathways see: [https://www.wikipathways.org/index.php/Pathway:WP4571 WP4571]</Comment>
  <Comment Source="WikiPathways-description">The urea cycle converts toxic nitrogenous compounds to excretable urea in five biochemical reactions. It is also the source for endogenous arginine, ornithine and citrulline production. The process mainly takes place in the liver, partly in the mitochondria and partly in the cytoplasm of the hepatocytes. There are several pathways associated with  the urea cycle and with the associated disorders, parts of these pathways are also pictured here.  
Because there is no alternative way to convert toxic nitrogenous compounds, defects in the enzymes or transporters can lead to several diseases (diseases highlighted in pink). The diseases are characterised by hyperammonemia, respiratory alkalosis and encephalopathy and the severity of the disease depends on the severity of the defect and the place of the defect in the cycle. Severe forms usually have an onset in infancy, while mild forms can also present in adulthood. 
This pathway was inspired by Chapter 4 of the book of Blau (ISBN 3642403360 (978-3642403361)). 
For the Urea cycle without additional pathways see: WP4571</Comment>
  <Graphics BoardWidth="1645.0597019687543" BoardHeight="916.0432493236489"/>
  <DataNode TextLabel="ARG1" GraphId="a0a6c" Type="Protein">
        </DataNode>
  <DataNode TextLabel="GLS2" GraphId="a386c" Type="Protein">
        </DataNode>
  <DataNode TextLabel="P5CS" GraphId="a58a3" Type="Protein">
        </DataNode>
  <DataNode TextLabel="a-Ketoglutarate" GraphId="aaacd" Type="Metabolite">
    <Comment>aka 2-oxoglutarate</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Citrulline" GraphId="aceea" Type="Metabolite">
    <Comment>Zwitterion needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="1-Pyrroline-&#10;5-carboxylate" GraphId="b328c" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Citrin&#10;(SLC25A13)" GraphId="b7f1d" Type="Protein">
    <Comment>AKA CTLN2, SLC25A13, AGC2</Comment>
    <BiopaxRef>c42</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Aspartate" GraphId="b963d" Type="Metabolite">
    <Comment>(1-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ASS1" GraphId="bb249" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Acetyl-CoA" GraphId="c021b" Type="Metabolite">
    <Comment>(4-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="L-Glutamatey-&#10;semialdehyde" GraphId="c2700" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ASL" GraphId="c3b06" Type="Protein">
        </DataNode>
  <DataNode TextLabel="GDH" GraphId="c505b" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Pyrimidine &#10;metabolism&#10;and diseases" GraphId="c5af8" Type="Pathway">
    <Graphics ShapeType="RoundedRectangle" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="Oxalacetate" GraphId="c6486" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="LDH" GraphId="c989b" Type="Protein">
        </DataNode>
  <DataNode TextLabel="ALT" GraphId="cdcc9" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Argininosuccinate" GraphId="cde55" Type="Metabolite">
    <Comment>(1-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Ornithine" GraphId="d0c2b" Type="Metabolite">
    <Comment>(1) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="NAGS" GraphId="d0c7a" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Urea" GraphId="d557a" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Proline" GraphId="d9405" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Glutamate" GraphId="d9e4b" Type="Metabolite">
    <Comment>(1-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Carbamoyl-phosphate" GraphId="df5b8" Type="Metabolite">
    <Comment>(2-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="MDH&#10;" GraphId="e34ba" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Fumarate" GraphId="e3761" Type="Metabolite">
    <Comment>(2-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="NH4+" GraphId="e408f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Aspartate &#10;metabolism" GraphId="e9580" Type="Pathway">
    <Graphics ShapeType="RoundedRectangle" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="MDH2" GraphId="ea55a" Type="Protein">
        </DataNode>
  <DataNode TextLabel="N-acetylglutamate" GraphId="eb661" Type="Metabolite">
    <Comment>(2-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="OTC" GraphId="ebf10" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Pyruvate" GraphId="ebf6f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Lactate" GraphId="ec30f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="OAT" GraphId="ecbc9" Type="Protein">
        </DataNode>
  <DataNode TextLabel="SLC25A12" GraphId="ef76b" Type="Protein">
    <Comment>AKA AGC1</Comment>
    <BiopaxRef>c42</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Glutamine" GraphId="f06ad" Type="Metabolite">
    <Comment>Zwitterion needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="AST2" GraphId="f4a78" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Alanine" GraphId="f4abd" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Malate" GraphId="f5eaa" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="FUM" GraphId="f8a7a" Type="Protein">
        </DataNode>
  <DataNode TextLabel="P5CR" GraphId="f9472" Type="Protein">
        </DataNode>
  <DataNode TextLabel="HCO3-" GraphId="fd346" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CPS1" GraphId="eb5bf" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Aspartate" GraphId="f50c6" Type="Metabolite">
    <Comment>(1-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Arginine" GraphId="a0b3d" Type="Metabolite">
    <Comment>(1) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Ornithine" GraphId="cfd3f" Type="Metabolite">
    <Comment>(1) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ORNT1" GraphId="c5b2d" Type="Protein">
    <Comment>Exchanges ornithine for citruline</Comment>
        </DataNode>
  <DataNode TextLabel="Citrulline" GraphId="c8e82" Type="Metabolite">
    <Comment>Zwitterion needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Oxalacetate" GraphId="d0b71" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Glutamate" GraphId="e2cf6" Type="Metabolite">
    <Comment>(1-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="a-Ketoglutarate" GraphId="befa0" Type="Metabolite">
    <Comment>aka 2-oxoglutarate</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="AST" GraphId="cba75" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Pyrimidine metabolism&#10;and diseases" GraphId="cc301" Type="Pathway">
    <Graphics ShapeType="RoundedRectangle" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="Orotate" GraphId="a7112" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="OMP" GraphId="ce782" Type="Metabolite">
    <Comment>Orotidylic acid</Comment>
    <Comment>(3-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Uridine" GraphId="c8187" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="UMP" GraphId="b1f04" Type="Metabolite">
    <Comment>(2-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Uracil" GraphId="dfe59" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Orotidine" GraphId="b95a6" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Carbamoyl-phosphate" GraphId="e032c" Type="Metabolite">
    <Comment>(2-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="NH4+" GraphId="af3a7" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Nitric oxide" GraphId="a9d9a" Type="Metabolite">
    <Comment>(1) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="iNOS" GraphId="e0eef" Type="Protein">
    <Comment>"Nitric oxide synthases (EC 1.14.13.39) (NOSs) are a family of enzymes catalyzing the production of nitric oxide (NO) from L-arginine. NO is an important cellular signaling molecule." [https://en.wikipedia.org/wiki/Nitric_oxide_synthase#iNOS].</Comment>
    <Comment> iNOS (inducible) is the protein active in hepatocytes, immune and cardiovascular system.</Comment>
    <Comment>aka NOS2</Comment>
        </DataNode>
  <DataNode TextLabel="Urea Cycle" GraphId="bf599" Type="Pathway">
    <Graphics ShapeType="RoundedRectangle" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="Malate" GraphId="b6b14" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Oxalacetate" GraphId="d29b0" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Glutamate" GraphId="f7cf8" Type="Metabolite">
    <Comment>(1-) charge needed for conversion to take place</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="nNOS" GraphId="bf827" Type="Protein">
    <Comment>"Nitric oxide synthases (EC 1.14.13.39) (NOSs) are a family of enzymes catalyzing the production of nitric oxide (NO) from L-arginine. NO is an important cellular signaling molecule." [https://en.wikipedia.org/wiki/Nitric_oxide_synthase#iNOS].</Comment>
    <Comment> nNOS (neuronal) is the protein active in nervous tissue and skeletal muscle type II.</Comment>
    <Comment>AKA NOS1</Comment>
        </DataNode>
  <DataNode TextLabel="eNOS" GraphId="b698d" Type="Protein">
    <Comment>"Nitric oxide synthases (EC 1.14.13.39) (NOSs) are a family of enzymes catalyzing the production of nitric oxide (NO) from L-arginine. NO is an important cellular signaling molecule." [https://en.wikipedia.org/wiki/Nitric_oxide_synthase#iNOS].</Comment>
    <Comment>eNOS (endotheiliall) is the protein active in endothelium</Comment>
    <Comment>AKA NOS3, cNOS</Comment>
        </DataNode>
  <Interaction GraphId="id1a76b0b5">
    <Graphics>
      <Point GraphRef="e2cf6"/>
      <Point GraphRef="f49c0" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id1bfba507">
    <Graphics>
      <Point GraphRef="f707e"/>
      <Point GraphRef="a9d9a" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id22c9db46">
    <Graphics>
      <Point GraphRef="bf827"/>
      <Point GraphRef="f707e" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id275adc5d">
    <Comment>Interaction mostly occurs in intestine, only important for ureagenesis during fasting.</Comment>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d9e4b"/>
      <Point/>
      <Point GraphRef="c2700" ArrowHead="mim-conversion"/>
      <Anchor Position="0.8880917742688886" Shape="None" GraphId="af41b"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id28a2473">
    <Graphics>
      <Point GraphRef="e6097"/>
      <Point GraphRef="c6486" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id2c81a5cf">
    <Graphics>
      <Point GraphRef="e0eef"/>
      <Point GraphRef="f707e" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id2cce663d">
    <Graphics>
      <Point GraphRef="c505b"/>
      <Point GraphRef="cb7de" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id3316efcb">
    <Graphics>
      <Point GraphRef="e34ba"/>
      <Point GraphRef="e9961" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id33ef49f0">
    <Graphics>
      <Point GraphRef="e597e"/>
      <Point GraphRef="e2cf6" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id343841e5">
    <Graphics>
      <Point GraphRef="ff51f"/>
      <Point GraphRef="d557a" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id3d7c6cbb">
    <Graphics>
      <Point GraphRef="b7f1d"/>
      <Point GraphRef="e33cc" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id3ea4065">
    <Graphics>
      <Point GraphRef="cb7de"/>
      <Point GraphRef="af3a7" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id45b3b640">
    <Graphics>
      <Point GraphRef="a386c"/>
      <Point GraphRef="d40e5" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id493094ab">
    <Graphics>
      <Point GraphRef="dfe59"/>
      <Point GraphRef="c7af0"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id4ebea5e4">
    <Graphics>
      <Point GraphRef="cba75"/>
      <Point GraphRef="f49c0" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id5068e">
    <Graphics>
      <Point GraphRef="aceea"/>
      <Point GraphRef="cde55" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4608642311248349" Shape="None" GraphId="b8adc"/>
      <Anchor Position="0.6928810649346776" Shape="None" GraphId="c3934"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id50794f48">
    <Graphics>
      <Point GraphRef="c989b"/>
      <Point GraphRef="d9718" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id5663c9fa">
    <Graphics>
      <Point GraphRef="d29b0"/>
      <Point GraphRef="a4712" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id59aeda63">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d9e4b"/>
      <Point/>
      <Point GraphRef="aaacd" ArrowHead="mim-conversion"/>
      <Anchor Position="0.2943101890209698" Shape="None" GraphId="cb7de"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id5dc1d8e2">
    <Graphics LineStyle="Broken">
      <Point GraphRef="cc301"/>
      <Point GraphRef="a7112" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id5ee98912">
    <Graphics>
      <Point GraphRef="ebf6f"/>
      <Point GraphRef="ec30f" ArrowHead="Arrow"/>
      <Anchor Position="0.3727682945669628" Shape="None" GraphId="d9718"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id6332b611">
    <Graphics>
      <Point GraphRef="f5eaa"/>
      <Point GraphRef="d0b71" ArrowHead="mim-conversion"/>
      <Anchor Position="0.6368661875847755" Shape="None" GraphId="e9961"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id637f270">
    <Graphics>
      <Point GraphRef="c5b2d"/>
      <Point GraphRef="c6602" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id63a83e39">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="a0b3d"/>
      <Point GraphRef="aceea" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="f707e"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id667763d">
    <Graphics>
      <Point GraphRef="f8a7a"/>
      <Point GraphRef="c57e2" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id6a2af133">
    <Graphics>
      <Point GraphRef="f49c0"/>
      <Point GraphRef="befa0" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id6f7be690">
    <Comment>allosteric activation</Comment>
    <Graphics>
      <Point GraphRef="eb661"/>
      <Point GraphRef="eb5bf" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id6f9026bc">
    <Graphics>
      <Point GraphRef="b95a6"/>
      <Point GraphRef="c7af0"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id724a4c21">
    <Graphics>
      <Point GraphRef="a0a6c"/>
      <Point GraphRef="ff51f" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id72a3ad7a">
    <Graphics>
      <Point GraphRef="f4abd"/>
      <Point GraphRef="ebf6f" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4975252135495209" Shape="None" GraphId="e597e"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id770fb9c0">
    <Graphics>
      <Point GraphRef="b698d"/>
      <Point GraphRef="f707e" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id77b295b1">
    <Graphics>
      <Point GraphRef="eb5bf"/>
      <Point GraphRef="fcfdc" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id77e8afcf">
    <Graphics>
      <Point GraphRef="a4712"/>
      <Point GraphRef="b963d" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id781f4666">
    <Graphics>
      <Point GraphRef="d9e4b"/>
      <Point GraphRef="eb661" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4278419212628186" Shape="None" GraphId="a7139"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id79ecffa3">
    <Graphics>
      <Point GraphRef="d40e5"/>
      <Point GraphRef="e408f" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id7dfb0edc">
    <Graphics>
      <Point GraphRef="f9472"/>
      <Point GraphRef="b93f3" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id87d86812">
    <Graphics>
      <Point GraphRef="fd346"/>
      <Point GraphRef="fcfdc" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8b9aebcd">
    <BiopaxRef>b2c</BiopaxRef>
    <Graphics>
      <Point GraphRef="b328c"/>
      <Point GraphRef="d9405" ArrowHead="mim-conversion"/>
      <Anchor Position="0.20486114833425495" Shape="None" GraphId="b93f3"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8be50834">
    <Graphics>
      <Point GraphRef="f06ad"/>
      <Point GraphRef="d9e4b" ArrowHead="mim-conversion"/>
      <Anchor Position="0.14279707660156124" Shape="None" GraphId="d40e5"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8c9bdf6d">
    <Graphics>
      <Point GraphRef="d0c2b"/>
      <Point GraphRef="c8e82" ArrowHead="mim-conversion"/>
      <Anchor Position="0.22342185896502362" Shape="None" GraphId="f37d5"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8e1fb0a2">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="a7112"/>
      <Point/>
      <Point/>
      <Point GraphRef="c7af0"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8f5513a2">
    <Graphics>
      <Point GraphRef="ecbc9"/>
      <Point GraphRef="e572a" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id9802ed5">
    <Graphics>
      <Point GraphRef="d4130"/>
      <Point GraphRef="e3761" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id9c1c7a1">
    <Graphics>
      <Point GraphRef="df5b8"/>
      <Point GraphRef="f37d5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.7279605926478412" Shape="None" GraphId="d6894"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id9d4b9d59">
    <Comment>Interaction mostly occurs in intestine, only important for ureagenesis during fasting.</Comment>
    <Graphics>
      <Point GraphRef="c2700"/>
      <Point GraphRef="d0c2b" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="e572a"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ida6c772f1">
    <Graphics>
      <Point GraphRef="b6b14"/>
      <Point GraphRef="d29b0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5185622728543969" Shape="None" GraphId="d76a5"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idab5647e6">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d9e4b"/>
      <Point/>
      <Point GraphRef="aaacd" ArrowHead="mim-conversion"/>
      <Anchor Position="0.911222966072883" Shape="None" GraphId="a4712"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb14a0c6c">
    <Graphics>
      <Point GraphRef="c021b"/>
      <Point GraphRef="a7139" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb5ec1076">
    <Graphics>
      <Point GraphRef="f50c6"/>
      <Point GraphRef="b8adc" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb6535337">
    <Graphics>
      <Point GraphRef="c3b06"/>
      <Point GraphRef="d4130" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb827cfa0">
    <Graphics>
      <Point GraphRef="f4a78"/>
      <Point GraphRef="a4712" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbe8d668">
    <Graphics>
      <Point GraphRef="befa0"/>
      <Point GraphRef="e597e" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idc49bc7c8">
    <Graphics>
      <Point GraphRef="e408f"/>
      <Point GraphRef="df5b8" ArrowHead="mim-conversion"/>
      <Anchor Position="0.698667960850904" Shape="None" GraphId="fcfdc"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idc98a52b3">
    <Graphics>
      <Point GraphRef="d0b71"/>
      <Point GraphRef="f50c6" ArrowHead="mim-conversion"/>
      <Anchor Position="0.36403112061467885" Shape="None" GraphId="f49c0"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idca222d0a">
    <Graphics>
      <Point GraphRef="c8e82"/>
      <Point GraphRef="aceea"/>
      <Anchor Position="0.458331835070071" Shape="None" GraphId="c6602"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idcefb4061">
    <Graphics>
      <Point GraphRef="a58a3"/>
      <Point GraphRef="af41b" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idcf863285">
    <Graphics>
      <Point GraphRef="f4a78"/>
      <Point GraphRef="e6097" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idcfe426f4">
    <Graphics>
      <Point GraphRef="f26bb"/>
      <Point GraphRef="f06ad"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd11e7cb4">
    <Graphics>
      <Point GraphRef="cfd3f"/>
      <Point GraphRef="d0c2b"/>
      <Anchor Position="0.5512212986390216" Shape="None" GraphId="c88b8"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd2d2f536">
    <Graphics>
      <Point GraphRef="d557a"/>
      <Point GraphRef="c7af0"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd4e3dad4">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="df5b8"/>
      <Point GraphRef="e032c"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd72eba58">
    <Graphics>
      <Point GraphRef="c5b2d"/>
      <Point GraphRef="c88b8" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd882d741">
    <Graphics>
      <Point GraphRef="bb249"/>
      <Point GraphRef="b8adc" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd9204f9a">
    <Comment>chemical conversion</Comment>
    <Graphics>
      <Point GraphRef="c2700"/>
      <Point GraphRef="b328c" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd9db37c4">
    <Graphics>
      <Point GraphRef="f06ad"/>
      <Point GraphRef="c5af8" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide04e3afd">
    <Graphics>
      <Point GraphRef="a0b3d"/>
      <Point GraphRef="cfd3f" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5390662293706172" Shape="None" GraphId="ff51f"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide659e37e">
    <Graphics>
      <Point GraphRef="d0c7a"/>
      <Point GraphRef="a7139" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ideddd9ba0">
    <Graphics>
      <Point GraphRef="cdcc9"/>
      <Point GraphRef="e597e" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idee5841fe">
    <Graphics>
      <Point GraphRef="ea55a"/>
      <Point GraphRef="d76a5" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idee9909ab">
    <Graphics>
      <Point GraphRef="ebf10"/>
      <Point GraphRef="d6894" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf5d3306f">
    <Graphics>
      <Point GraphRef="cde55"/>
      <Point GraphRef="a0b3d" ArrowHead="mim-conversion"/>
      <Anchor Position="0.13776950368791238" Shape="None" GraphId="d4130"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf77f0b0">
    <Graphics>
      <Point GraphRef="aaacd"/>
      <Point GraphRef="d9e4b" ArrowHead="mim-conversion"/>
      <Anchor Position="0.51380856992799" Shape="None" GraphId="e6097"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf805350e">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="f5eaa"/>
      <Point GraphRef="b6b14" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idfc69c9f">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e3761"/>
      <Point GraphRef="f5eaa" ArrowHead="mim-conversion"/>
      <Anchor Position="0.8533173938865793" Shape="None" GraphId="c57e2"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idfdd79351">
    <Graphics>
      <Point GraphRef="e2cf6"/>
      <Point GraphRef="f7cf8"/>
      <Anchor Position="0.4" Shape="None" GraphId="abb56"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d7e1b">
    <Graphics>
      <Point GraphRef="ce782"/>
      <Point GraphRef="b95a6" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c5205">
    <Graphics>
      <Point GraphRef="ce782"/>
      <Point GraphRef="b1f04" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b15eb">
    <Graphics>
      <Point GraphRef="a7112"/>
      <Point GraphRef="ce782" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eba2d">
    <Graphics>
      <Point GraphRef="b1f04"/>
      <Point GraphRef="c8187" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f5340">
    <Graphics>
      <Point GraphRef="c8187"/>
      <Point GraphRef="dfe59" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ea3f6">
    <Graphics>
      <Point GraphRef="f26bb"/>
      <Point GraphRef="f4abd"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e679b">
    <Graphics LineStyle="Broken">
      <Point GraphRef="e032c"/>
      <Point GraphRef="cc301" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ed4b3">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="ec30f"/>
      <Point/>
      <Point GraphRef="b60fd"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b76f2">
    <Graphics>
      <Point GraphRef="b963d"/>
      <Point GraphRef="f50c6"/>
      <Anchor Position="0.4" Shape="None" GraphId="e33cc"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0cc9">
    <Graphics>
      <Point GraphRef="b7f1d"/>
      <Point GraphRef="abb56" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e366f">
    <Graphics>
      <Point GraphRef="ef76b"/>
      <Point GraphRef="abb56" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="da8c6">
    <Graphics>
      <Point GraphRef="ef76b"/>
      <Point GraphRef="e33cc" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GraphId="a45d0">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d40e5"/>
      <Point GraphRef="c116b" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a720c">
    <BiopaxRef>cf7</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="d6894"/>
      <Point GraphRef="c3367" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a8eb8">
    <BiopaxRef>b08</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="a7139"/>
      <Point GraphRef="d2236" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="dd209">
    <BiopaxRef>a94</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="fcfdc"/>
      <Point GraphRef="a0cdd" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="de190">
    <BiopaxRef>b59</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="e33cc"/>
      <Point GraphRef="e1ba9" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e494f">
    <BiopaxRef>dda</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="b8adc"/>
      <Point GraphRef="f82c2" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="eacfe">
    <BiopaxRef>f13</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="c5b2d"/>
      <Point GraphRef="afb9a" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f711d">
    <BiopaxRef>f42</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="ff51f"/>
      <Point GraphRef="abe26" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f71f4">
    <BiopaxRef>b16</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="d4130"/>
      <Point GraphRef="c826f" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="faa6f">
    <Graphics LineStyle="Broken">
      <Point GraphRef="af41b"/>
      <Point GraphRef="b5da8" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f8d56">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d0dde">
    <Graphics LineStyle="Broken">
      <Point/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ae48e">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-catalysis"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cadd8">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cc3b0">
    <BiopaxRef>ba1</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="e33cc"/>
      <Point GraphRef="fd561" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="Urine" GraphId="c7af0">
    <Graphics FillColor="ffffcc" ShapeType="RoundedRectangle" Color="404040"/>
  </Label>
  <Label TextLabel="Suprahepatic Blood" GraphId="b60fd">
    <Graphics FillColor="ff9999" ShapeType="RoundedRectangle" Color="404040"/>
  </Label>
  <Label TextLabel="Unknown aethiology" GraphId="b8ce6">
    <Graphics FillColor="ffffff" Color="404040"/>
  </Label>
  <Label TextLabel="Chemical" GraphId="ce17d">
    <Graphics FillColor="ffffff" Color="404040"/>
  </Label>
  <Label TextLabel="N-acetylglutamate &#10;synthase deficiency" GraphId="d2236" Href="https://omim.org/237310">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Insufficient supply of NAD" GraphId="d8686">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="In hepatocytes" GraphId="e5427">
    <Graphics FillColor="ffffff" Color="404040"/>
  </Label>
  <Label TextLabel="Interactions mostly &#10;occurs in intestine" GraphId="eb0f1">
    <Graphics FillColor="ffffff" Color="404040"/>
  </Label>
  <Label TextLabel="AGC1/2" GraphId="efd32">
    <Comment>Mitochondrial aspartate-glutamate carriers</Comment>
    <Graphics FillColor="ffffff" Color="404040"/>
  </Label>
  <Label TextLabel="Portal Blood" GraphId="f26bb">
    <Graphics FillColor="ff9999" ShapeType="RoundedRectangle" Color="404040"/>
  </Label>
  <Label TextLabel="Mitochondrion" GraphId="f35b4">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Carbamoyl-&#10;phosphate &#10;synthetase I &#10;deficiency" GraphId="a0cdd" Href="https://omim.org/237300">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Arginase &#10;deficiency" GraphId="abe26" Href="https://omim.org/207800">
    <Comment>aka Hyperargininemia, argininemia, arginase 1 deficiency</Comment>
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Arginino-&#10;succinic &#10;aciduria " GraphId="c826f" Href="https://omim.org/207900">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Citrullinemia &#10;type I " GraphId="f82c2" Href="https://omim.org/215700">
    <Comment>aka Argininosuccinate Synthetase Deficiency</Comment>
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Ornithine &#10;transcarbamylase &#10;deficiency" GraphId="c3367" Href="https://omim.org/311250">
    <Comment>aka Ornithine Carbamoyltransferase Deficiency</Comment>
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Ornithine &#10;translocase &#10;deficiency" GraphId="afb9a" Href="https://omim.org/238970">
    <Comment>aka Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome or HHH syndrome</Comment>
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Citrullinemia Type II,&#10;Neonatal-onset" GraphId="e1ba9" Href="https://omim.org/605814">
    <Comment>aka Citrullinemia Type II</Comment>
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Pyrroline-&#10;5-carboxylate &#10;synthase &#10;deficiency" GraphId="b5da8" Href="https://omim.org/219150">
    <Comment>DISEASE</Comment>
    <Comment>aka Hypoprolinaemia</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Glutamine &#10;synthetase &#10;deficiency" GraphId="c116b" Href="https://omim.org/610015">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Cytosol" GraphId="c339c">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Disease" GraphId="fe5d2">
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Catalysis" GraphId="fb7a4">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Pathway" GraphId="f4e85">
    <Graphics FillColor="ffffff" ShapeType="RoundedRectangle" Color="009933"/>
  </Label>
  <Label TextLabel="Stimulation" GraphId="ce66a">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Protein" GraphId="f0dc2">
    <Graphics FillColor="ffffff" ShapeType="Rectangle"/>
  </Label>
  <Label TextLabel="Metabolite" GraphId="a228b">
    <Graphics FillColor="ffffff" ShapeType="Rectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Conversion" GraphId="c7fae">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Connection &#10;to disease&#10;" GraphId="ef85f">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Legend" GraphId="d6148">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Citrullinemia Type II,&#10;Adult-onset" GraphId="fd561" Href="https://omim.org/603471">
    <Comment>aka Citrullinemia Type II</Comment>
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Protein with &#10;specfic&#10;localisation &#10;information" GraphId="ef66c">
    <Graphics FillColor="ffffff" ShapeType="Rectangle"/>
  </Label>
  <Label TextLabel="In nervous tissue,&#10;skeletal muscle Type II" GraphId="a1a7f">
    <Graphics FillColor="ffffff" Color="404040"/>
  </Label>
  <Label TextLabel="In endothelium" GraphId="b8ea7">
    <Graphics FillColor="ffffff" Color="404040"/>
  </Label>
  <Label TextLabel="THAN" GraphId="f9360">
    <Comment>aka transient hyperammonemia of the newborn/prematurity.</Comment>
    <Comment>DISEASE</Comment>
    <Comment>Unconfirmed aethiology, however "transient hyperammonemia is known to be caused by increased levels of ammonia in the blood stream, as well as a failure of the urea cycle to convert enough of the ammonia into urea." [https://en.wikipedia.org/wiki/Transient_hyperammonemia_of_the_newborn]</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Shape GraphId="a27ee">
    <Graphics FillColor="ffcc99" ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape GraphId="f333a">
    <Graphics FillColor="ccffcc" ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape GraphId="e3b5f">
    <Graphics ShapeType="Mitochondria" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="e7989">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape GraphId="f908e">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="f08ee">
    <Graphics ShapeType="RoundedRectangle" LineStyle="Broken" Color="c0c0c0"/>
  </Shape>
  <InfoBox/>
  <Biopax>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >disease pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000013</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b16">
      <bp:ID >30158522</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer</bp:TITLE>
      <bp:SOURCE >Nat Commun</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Baruteau J</bp:AUTHORS>
      <bp:AUTHORS >Perocheau DP</bp:AUTHORS>
      <bp:AUTHORS >Hanley J</bp:AUTHORS>
      <bp:AUTHORS >Lorvellec M</bp:AUTHORS>
      <bp:AUTHORS >Rocha-Ferreira E</bp:AUTHORS>
      <bp:AUTHORS >et al.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >ornithine carbamoyltransferase deficiency</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:9271</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf7">
      <bp:ID >28293384</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hyperammonemia crisis following parturition in a female patient with ornithine transcarbamylase deficiency</bp:TITLE>
      <bp:SOURCE >World J Hepatol</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Kido J</bp:AUTHORS>
      <bp:AUTHORS >Kawasaki T</bp:AUTHORS>
      <bp:AUTHORS >Mitsubuchi H</bp:AUTHORS>
      <bp:AUTHORS >Kamohara H</bp:AUTHORS>
      <bp:AUTHORS >Ohba T</bp:AUTHORS>
      <bp:AUTHORS >Matsumoto S</bp:AUTHORS>
      <bp:AUTHORS >Endo F</bp:AUTHORS>
      <bp:AUTHORS >Nakamura K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f13">
      <bp:ID >16940241</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome</bp:TITLE>
      <bp:SOURCE >Pediatr Res</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Camacho JA</bp:AUTHORS>
      <bp:AUTHORS >Mardach R</bp:AUTHORS>
      <bp:AUTHORS >Rioseco-Camacho N</bp:AUTHORS>
      <bp:AUTHORS >Ruiz-Pesini E</bp:AUTHORS>
      <bp:AUTHORS >Derbeneva O</bp:AUTHORS>
      <bp:AUTHORS >Andrade D</bp:AUTHORS>
      <bp:AUTHORS >Zaldivar F</bp:AUTHORS>
      <bp:AUTHORS >Qu Y</bp:AUTHORS>
      <bp:AUTHORS >Cederbaum SD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >urea cycle disorder</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:9267</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b2c">
      <bp:ID >2722838</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Purified human erythrocyte pyrroline-5-carboxylate reductase. Preferential oxidation of NADPH.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1989</bp:YEAR>
      <bp:AUTHORS >Merrill MJ</bp:AUTHORS>
      <bp:AUTHORS >Yeh GC</bp:AUTHORS>
      <bp:AUTHORS >Phang JM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b08">
      <bp:ID >30337552</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >N-Acetylglutamate Synthase Deficiency Due to a Recurrent Sequence Variant in the N-acetylglutamate Synthase Enhancer Region</bp:TITLE>
      <bp:SOURCE >Sci Rep</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Williams M</bp:AUTHORS>
      <bp:AUTHORS >Burlina A</bp:AUTHORS>
      <bp:AUTHORS >Rubert L</bp:AUTHORS>
      <bp:AUTHORS >Polo G</bp:AUTHORS>
      <bp:AUTHORS >Ruijter GJG</bp:AUTHORS>
      <bp:AUTHORS >et al.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >hepatocyte</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >CL:0000182</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a94">
      <bp:ID >28658158</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Neonatal-onset carbamoyl phosphate synthetase I deficiency: A case report.</bp:TITLE>
      <bp:SOURCE >Medicine (Baltimore)</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Yang X</bp:AUTHORS>
      <bp:AUTHORS >Shi J</bp:AUTHORS>
      <bp:AUTHORS >Lei H</bp:AUTHORS>
      <bp:AUTHORS >Xia B</bp:AUTHORS>
      <bp:AUTHORS >Mu D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c42">
      <bp:ID >27132995</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >AGC1/2, the mitochondrial aspartate-glutamate carriers.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >2016</bp:YEAR>
      <bp:AUTHORS >Amoedo ND</bp:AUTHORS>
      <bp:AUTHORS >Punzi G</bp:AUTHORS>
      <bp:AUTHORS >Obre E</bp:AUTHORS>
      <bp:AUTHORS >Lacombe D</bp:AUTHORS>
      <bp:AUTHORS >De Grassi A</bp:AUTHORS>
      <bp:AUTHORS >Pierri CL</bp:AUTHORS>
      <bp:AUTHORS >Rossignol R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f42">
      <bp:ID >20301338</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Arginase deficiency</bp:TITLE>
      <bp:SOURCE >GeneReview&#174; [Internet]</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >20301338</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Arginase deficiency</bp:TITLE>
      <bp:SOURCE >GeneReviews&#174; [Internet]</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >20301338</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Arginase deficiency</bp:TITLE>
      <bp:SOURCE >GeneReviews&#174; [Internet]</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Derek Wong</bp:AUTHORS>
      <bp:AUTHORS >Stephen Cederbaum</bp:AUTHORS>
      <bp:AUTHORS >Eric A Crombez</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >argininosuccinic aciduria</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:14755</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >citrullinemia</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:9273</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >carbamoyl phosphate synthetase I deficiency disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:9280</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dda">
      <bp:ID >20301631</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Citrullinemia Type I</bp:TITLE>
      <bp:SOURCE >GeneReviews&#174; [Internet]</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >20301631</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Citrullinemia Type I</bp:TITLE>
      <bp:SOURCE >GeneReviews&#174; [Internet]</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >20301631</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Citrullinemia Type I</bp:TITLE>
      <bp:SOURCE >GeneReviews&#174; [Internet]</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Shane C Quinonez</bp:AUTHORS>
      <bp:AUTHORS >Jess G Thoene</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >inborn error of urea cycle pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0002142</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >urea cycle pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000076</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b59">
      <bp:ID >20301360</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Citrin Deficiency</bp:TITLE>
      <bp:SOURCE >GeneReviews&#174; [Internet]</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:ID >20301360</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Citrin Deficiency</bp:TITLE>
      <bp:SOURCE >GeneReviews&#174; [Internet]</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:ID >20301360</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Citrin Deficiency</bp:TITLE>
      <bp:SOURCE >GeneReviews&#174; [Internet]</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Takeyori Saheki</bp:AUTHORS>
      <bp:AUTHORS >Yuan-Zong Song</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba1">
      <bp:ID >30588060</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Adult-onset type II citrullinemia: Current insights and therapy.</bp:TITLE>
      <bp:SOURCE >Appl Clin Genet</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Hayasaka K</bp:AUTHORS>
      <bp:AUTHORS >Numakura C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >hyperargininemia</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:9278</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
  </Biopax>
</Pathway>